Balance between bone morphogenetic proteins and their antagonists in kidney injury

Therapeutic Apheresis and Dialysis

Volumn 11, Issue SUPPL. 1, 2007, Pages

  Yanagita, Motoko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antagonist; Bone morphogenetic protein; Uterine sensitization associated gene 1

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN ANTAGONIST; OSTEOGENIC PROTEIN 1; PROTEIN ANTIBODY; SMAD PROTEIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG ANTAGONISM; DRUG MECHANISM; DRUG SCREENING; GENE; KIDNEY FUNCTION; KIDNEY INJURY; MODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RENAL PROTECTION; UTERINE SENSITIZATION ASSOCIATED GENE 1; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEINS; HUMANS; KIDNEY; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 35748957452     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00520.x     Document Type: Conference Paper

References (3)

1. Yanagita M, Oka M, Watabe T et al. USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. BBRC 2004 316: 490 500.
2. Yanagita M, Okuda T, Endo S et al. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 2006 116: 70 9.
3. Yanagita M. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int 2006 70: 989 93.